28bio at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
28bio brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on the move to drug development without animal testing, including lessons from founding a biotech built first on non-animal methods and what it wishes regulators would ask.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Neurotechnology company using human brain organoids to test drug safety and efficacy, offering organoid products and testing services. | Talk Wed Oct 28 3:00pm–3:10pm Founding a NAMs-First Biotech in the Bayou: What Works, What Doesn’t, and What We Wish Regulators Asked For Preclinical, clinical and translational sciences Session Wed Oct 28 3:00pm–4:00pm Hot Topic: The Countdown to Post-Animal Drug Development: Disruptors on the Ground Preclinical, clinical and translational sciences Talk Wed Oct 28 3:40pm–4:00pm Panel Discussion Preclinical, clinical and translational sciences |
Instantly find 20 buyers from 28bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction